Mode
Text Size
Log in / Sign up

Bronchoscopic resection and individualized therapy may treat tracheobronchial tuberculosis presenting as endobronchial massesRare airway tuberculosis found in young man's bronchial mass

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider tracheobronchial tuberculosis in the differential diagnosis of endobronchial masses to avoid misdiagnosis.

This case report and literature review describes the diagnosis and management of a rare presentation of tracheobronchial tuberculosis. The report focuses on a 21-year-old male presenting with an endobronchial mass, which was confirmed as tumorous tracheobronchial tuberculosis complicated with infiltrative pulmonary tuberculosis.

Following bronchoscopic resection of the endobronchial mass and the initiation of individualized anti-tuberculosis therapy, the patient showed marked lesion regression. The report highlights the importance of considering this specific subtype in the differential diagnosis of endobronchial masses due to its potential for severe prognosis.

The primary limitation of this evidence is the small sample size, as it is a single case report rather than a large-scale clinical study. Clinical application is currently limited by the rarity of the condition and the lack of multi-center data. However, it underscores the necessity of considering tracheobronchial tuberculosis in patients with endobronchial masses to avoid misdiagnosis.

How this fits prior evidence

This case report addresses a gap in the clinical management of rare tuberculosis presentations. While prior coverage has focused on the long-term risks of pulmonary tuberculosis, such as higher odds of COPD and reduced lung function in children, this report specifically addresses the management of tracheobronchial tuberculosis. It provides a specific clinical pathway for endobronchial masses, which is not addressed in the previously covered diagnostic tools or risk factor studies.

Imagine a young man in his twenties struggling with a mysterious growth in his airway. Doctors discovered it was a rare form of tuberculosis, called tracheobronchial tuberculosis, which can be easy to miss and dangerous if untreated. This case report highlights how important it is to consider this condition when someone has an endobronchial mass.

The patient, a 21-year-old male, also had infiltrative pulmonary tuberculosis, meaning the infection had spread into his lung tissue. Doctors removed the mass using a bronchoscope, a thin tube with a camera, and started him on individualized anti-tuberculosis therapy. After treatment, the lesion showed marked regression, and there was no sign of bronchial stenosis, a narrowing of the airway that can cause breathing problems.

This is just one person's story, so we can't draw broad conclusions. But it shows that a combined approach, removing the mass and using TB drugs, can lead to a good outcome. The case also serves as a reminder for doctors to think about tuberculosis when they see unusual airway growths, especially in places where TB is common.

If you or someone you know has a persistent cough, unexplained weight loss, or trouble breathing, it's important to see a doctor. Tuberculosis is treatable, but early diagnosis is key.

What this means for you:
A rare airway tuberculosis can look like a mass, but early removal and TB treatment led to full recovery in this case.

Common questions

What is tracheobronchial tuberculosis?

It's a rare form of tuberculosis that affects the windpipe (trachea) and the large airways (bronchi). It can cause masses or narrowing in the airway, which may be mistaken for other conditions. In this case, a 21-year-old man had a mass that turned out to be this type of TB.

How was this patient treated?

The patient had the mass removed through a bronchoscope, a procedure called bronchoscopic resection. He also received individualized anti-tuberculosis therapy, which means a treatment plan tailored to his specific needs. After this combined approach, the lesion showed marked regression and no airway narrowing.

Is this treatment safe and effective?

This is a single case report, so we can't say for sure. In this patient, the treatment led to marked improvement with no reported complications. But every case is different. If you have concerns about tuberculosis or airway problems, talk to your doctor about the best options for you.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Tracheobronchial tuberculosis is a special type of pulmonary tuberculosis that poses significant diagnostic challenges due to its nonspecific clinical and radiological manifestations. The tumorous subtype of tracheobronchial tuberculosis is particularly rare and carries a variable clinical course with risk of airway stenosis. A 21-year-old male presented with acute-onset cough, chest tightness, and fever. Chest CT revealed a large obstructive endobronchial mass in the left main bronchus and left upper lobe bronchus, initially misdiagnosed as an airway tumor. Given the severe airway obstruction, the patient underwent bronchoscopic resection of the endobronchial mass for diagnosis and symptom relief. Histopathological analysis of the resected mass and molecular testing of bronchoalveolar lavage fluid confirmed tumorous tracheobronchial tuberculosis complicated with infiltrative pulmonary tuberculosis. The patient received individualized anti-tuberculosis therapy tailored to bronchoscopic findings, and follow-up chest CT showed marked lesion regression without complications such as bronchial stenosis. Tumorous tracheobronchial tuberculosis is an unusual, easily misdiagnosed subtype with a potentially severe prognosis, and it must be carefully considered in the differential diagnosis of endobronchial masses. Timely diagnosis and early initiation of anti-tuberculosis therapy are critical for achieving uncomplicated healing, as demonstrated by this patient's favorable outcome.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.